ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109451; 2) Community: the network communities that were significantly associated with the response to NSC 109451; 3) Molecule: the relationships between components within communities and NSC 109451; 4) MDR: the compounds that were significantly associated with the NSC 109451.

NSC Compound Enrichment Correlation
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.0386895225700407 -0.1218365
NSC 761039 Null 0.0386895225700407 -0.077930171
NSC 764039 AZD-5363 0.0386895225700407 0.41438655
NSC 372474 Null 0.0410413740044187 -0.17352427
NSC 671409 Null 0.0410413740044187 0.37604713
NSC 728323 16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0410413740044187 -0.12968131
NSC 125347 Null 0.0420420371076614 -0.29823801
NSC 169774 Bromocriptine methanesulfonate 0.0420420371076614 -0.15005356
NSC 237020 TA 1067 0.0420420371076614 0.001694566
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.0420420371076614 -0.15905302
Total:114  Current:83    [First] [Prev] [Next] [Last]